User profiles for Tuva Børresdatter Dahl
 | Tuva B DahlResearcher at Oslo University Hospital Verified email at medisin.uio.no Cited by 3641 |
Evaluation of the effects of remdesivir and hydroxychloroquine on viral clearance in COVID-19: a randomized trial
…, A Johannessen, L Heggelund, TB Dahl… - Annals of internal …, 2021 - acpjournals.org
Background: New treatment modalities are urgently needed for patients with COVID-19. The
World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or …
World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or …
Persistent pulmonary pathology after COVID-19 is associated with high viral load, weak antibody response, and high levels of matrix metalloproteinase-9
…, R Hannula, S Aballi, AB Kildal, R Eiken, TB Dahl… - Scientific Reports, 2021 - nature.com
The association between pulmonary sequelae and markers of disease severity, as well as
pro-fibrotic mediators, were studied in 108 patients 3 months after hospital admission for …
pro-fibrotic mediators, were studied in 108 patients 3 months after hospital admission for …
Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosis
…, HL Orrem, B Sporsheim, L Ryan, XY Kong, TB Dahl… - …, 2020 - thelancet.com
Background During atherogenesis, cholesterol precipitates into cholesterol crystals (CC) in
the vessel wall, which trigger plaque inflammation by activating the NACHT, LRR and PYD …
the vessel wall, which trigger plaque inflammation by activating the NACHT, LRR and PYD …
A complex role of activin A in non-alcoholic fatty liver disease
A Yndestad, JW Haukeland, TB Dahl… - Official journal of the …, 2009 - journals.lww.com
OBJECTIVES: Recent studies suggest that activin A, a member of the transforming growth
factor (TGF) superfamily, is involved in the pathogenesis of liver disorders. We sought to …
factor (TGF) superfamily, is involved in the pathogenesis of liver disorders. We sought to …
High circulating levels of the homeostatic chemokines CCL19 and CCL21 predict mortality and disease severity in COVID-19
…, P Aukrust, B Halvorsen, TB Dahl… - The Journal of …, 2022 - academic.oup.com
Background Immune dysregulation is a major factor in the development of severe coronavirus
disease 2019 (COVID-19). The homeostatic chemokines CCL19 and CCL21 have been …
disease 2019 (COVID-19). The homeostatic chemokines CCL19 and CCL21 have been …
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial
…, K Nezvalova-Henriksen, L Beniguel, TB Dahl… - Critical care, 2023 - Springer
Background Baricitinib has shown efficacy in hospitalized patients with COVID-19, but no
placebo-controlled trials have focused specifically on severe/critical COVID, including …
placebo-controlled trials have focused specifically on severe/critical COVID, including …
Respiratory dysfunction three months after severe COVID‐19 is associated with gut microbiota alterations
B Vestad, T Ueland, TV Lerum, TB Dahl… - Journal of Internal …, 2022 - Wiley Online Library
Background Although coronavirus disease 2019 (COVID‐19) is primarily a respiratory
infection, mounting evidence suggests that the gastrointestinal tract is involved in the disease, …
infection, mounting evidence suggests that the gastrointestinal tract is involved in the disease, …
Critical COVID‐19 is associated with distinct leukocyte phenotypes and transcriptome patterns
…, MJ Jørgensen, KG Nore, TB Dahl… - Journal of Internal …, 2021 - Wiley Online Library
Background Prognostic markers for disease severity and identification of therapeutic targets
in COVID‐19 are urgently needed. We have studied innate and adaptive immunity on …
in COVID‐19 are urgently needed. We have studied innate and adaptive immunity on …
Circulating markers of extracellular matrix remodelling in severe COVID‐19 patients
…, A Barratt‐Due, T Ueland, TB Dahl - Journal of Internal …, 2023 - Wiley Online Library
Background Abnormal remodelling of the extracellular matrix (ECM) has generally been
linked to pulmonary inflammation and fibrosis and may also play a role in the pathogenesis of …
linked to pulmonary inflammation and fibrosis and may also play a role in the pathogenesis of …
Low cellular NAD+ compromises lipopolysaccharide-induced inflammatory responses via inhibiting TLR4 signal transduction in human monocytes
NAD+ is an essential cofactor in reduction-oxidation metabolism with impact on metabolic
and inflammatory diseases. However, data elucidating the effects of NAD+ on the …
and inflammatory diseases. However, data elucidating the effects of NAD+ on the …